|
Media event:
|
Exploring the cost of non-compliance in hypertension and presenting new data from the telmisartan + amlodipine combination therapy |
|---|---|
|
Venue:
|
Milan, Italy
|
|
Website:
|
|
|
Newsflash:
|
Summary newsflash |
European Society of Hypertension
Background information for medical media outside the US only
-
Prof. Ettore Ambrosioni
Professor of internal medicine
Professor Ambrosioni is currently a member of the Scientific Council of European Society of Hypertension. He was Professor of Internal Medicine and Director of the Division of Internal Medicine, Clinica Medica III, Faculty of Medicine at the University of Bologna until 2004. He has authored or co-authored over 600 publications.
-
Dr Sarah Jarvis
Primary Care Practitioner, Richford Gate Medical Practice, London, United Kingdom
Sarah Jarvis is a GP, GP trainer, fellow of the Royal College of General Practitioners and Women's Health spokesperson for the RCGP. She is a member of the advisory board of the British Journal of Cardiology and the Healthcare Committee of HEART UK.
-
Prof. Guiseppe Mancia
Director of Clinical Medicine, University of Milano Bicocca
Professor Mancia is Professor of Medicine and Chairman of the Department of Medicine at the University of Milan-Biocca. He is currently Chairman of the Education Board of the European Society of Hypertension (ESH), as well as Chairman of the World Health Organization (WHO)/ISH Liasion Committee. He has edited several books on hypertension and has published more than 1,000 original paper, reviews and editorials.
-
Videos
-
'Newsflash' of Webcast
Highlights of key telmisartan news presented at ESH
-
Webcast on Demand
View the telmisartan webcast, in which Prof. Giuseppe Mancia, Prof. Ettore Ambrosioni and Dr Sarah Jarvis explore the cost of non-compliance in hypertension and present new data for the telmisartan + amlodipine combination therapy
-
Telmisartan and Amlodipine - an effective combination
-
The real cost of the wrong treatment
-
Why patients don't take treatment
-
